0001484612-22-000004.txt : 20220104 0001484612-22-000004.hdr.sgml : 20220104 20220104162954 ACCESSION NUMBER: 0001484612-22-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trigg Leslie CENTRAL INDEX KEY: 0001304125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39513 FILM NUMBER: 22506483 MAIL ADDRESS: STREET 1: C/O OUTSET MEDICAL STREET 2: 1830 BERING ROAD CITY: SAN JOSE STATE: CA ZIP: 95112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outset Medical, Inc. CENTRAL INDEX KEY: 0001484612 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 200514392 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 669-231-8200 MAIL ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: Home Dialysis Plus, Ltd. DATE OF NAME CHANGE: 20100219 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-01-03 0 0001484612 Outset Medical, Inc. OM 0001304125 Trigg Leslie 3052 ORCHARD DRIVE SAN JOSE CA 95134 1 1 0 0 Chief Executive Officer Common Stock 2022-01-03 4 M 0 20000 3.88 A 270567 D Common Stock 2022-01-03 4 S 0 20000 47.0976 D 250567 D Common Stock 2022-01-03 4 M 0 12500 3.88 A 263067 D Common Stock 2022-01-03 4 S 0 12500 47.0996 D 250567 D Common Stock 2022-01-03 4 M 0 10000 3.88 A 260567 D Common Stock 2022-01-03 4 S 0 10000 47.0866 D 250567 D Common Stock 8770 I Trigg Family Trust Non-Qualified Stock Option (right to buy) 3.88 2022-01-03 4 M 0 20000 0.0 D 2027-09-19 Common Stock 20000 138211 D Non-Qualified Stock Option (right to buy) 3.88 2022-01-03 4 M 0 12500 0.0 D 2027-09-19 Common Stock 12500 125711 D Non-Qualified Stock Option (right to buy) 3.88 2022-01-03 4 M 0 10000 0.0 D 2027-09-19 Common Stock 10000 115711 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 1,040 shares; $46.00-$46.99 - 3,779 shares; $47.00-$47.99 - 15,181 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 775 shares; $46.00-$46.99 - 1,691 shares; $47.00-$47.99 - 10,034 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 700 shares; $46.00-$46.99 - 1,784 shares; $47.00-$47.99 - 7,366; $48.00 - $48.99 - 150 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option vested in 48 equal monthly installments beginning on October 19, 2017. By: John L Brottem For: Leslie Trigg 2022-01-04